8-143650470-G-A
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001261843.2(ZNF623):c.478G>A(p.Val160Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000229 in 1,613,976 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001261843.2 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF623 | ENST00000526926.6 | c.478G>A | p.Val160Ile | missense_variant | Exon 2 of 2 | 2 | NM_001261843.2 | ENSP00000435232.1 | ||
ZNF623 | ENST00000458270.2 | c.478G>A | p.Val160Ile | missense_variant | Exon 2 of 2 | 1 | ENSP00000411139.2 | |||
ZNF623 | ENST00000501748.3 | c.598G>A | p.Val200Ile | missense_variant | Exon 1 of 1 | 6 | ENSP00000445979.1 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 152086Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000438 AC: 11AN: 251358 AF XY: 0.0000442 show subpopulations
GnomAD4 exome AF: 0.0000212 AC: 31AN: 1461890Hom.: 0 Cov.: 34 AF XY: 0.0000206 AC XY: 15AN XY: 727246 show subpopulations
GnomAD4 genome AF: 0.0000395 AC: 6AN: 152086Hom.: 0 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74290 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.598G>A (p.V200I) alteration is located in exon 1 (coding exon 1) of the ZNF623 gene. This alteration results from a G to A substitution at nucleotide position 598, causing the valine (V) at amino acid position 200 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at